IP Library Granted Patent US 9,539,300
Granted Patent B2
US 9,539,300 · App. 13/789,513 · Granted Jan 10, 2017

Modulating disease through genetic engineering of plants

Inventors: Alan M. Fogelman (Los Angeles, CA); Srinivasa T. Reddy (Cerritos, CA); Mohamad Navab (Los Angeles, CA)
Assignee: The Regents of the University of California
A61K38/10A23K10/30A23L19/00A23L33/10A23L33/185A61K36/81C07K14/775C12N15/8247C12N15/8257
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,539,300
App. No.
13/789,513
Granted
Jan 10, 2017
Kind
B2
Abstract

In certain embodiments transgenic plants (e.g., transgenic tomatoes) are provided that comprise cells that express a peptide one or more domains of which comprise the amino acid sequence of an apolipoprotein or apolipoprotein mimetic peptide where the peptide has biological activity (e.g., lowers SAA, and/or increases paroxonase activity, and/or improves HDL inflammatory index, etc.) when the plant and/or the peptide is fed to a mammal.

Claims (23)

1. A transgenic tomato plant comprising cells that express a peptide one or more domains of which comprise the amino acid sequence DWLKAFYDKFFEKFKEFF (SEQ ID NO: 17) wherein said peptide in a fruit of said plant is effective to decrease plasma levels of lysophosphatidic acid (LPA) in a mammal, and/or to decrease serum amyloid A (SAA) levels in said mammal, and/or to increase plasma paraoxonase activity in said mammal when said fruit is fed to said mammal as a lyophilized powder.

2. The transgenic plant of claim 1 , wherein said peptide comprises one domain that comprises the amino acid sequence of said apolipoprotein or apolipoprotein mimetic peptide.

3. The transgenic plant of claim 1 , wherein said peptide comprises at least two domains that comprise the amino acid sequence of said apolipoprotein or apolipoprotein mimetic peptide.

4. The transgenic plant of claim 1 , wherein the amino acid sequence of said peptide consists of the sequence DWLKAFYDKFFEKFKEFF (SEQ ID NO:17).

5. The transgenic plant of claim 1 , wherein said peptide in the fruit of said plant is effective to decrease plasma levels of lysophosphatidic acid (LPA) in a mammal, and/or to decrease serum amyloid A (SAA) levels in said mammal, and/or to increase plasma paraoxonase activity in said mammal when said fruit is fed to said mammal as a component of a food or diet.

6. The transgenic plant of claim 1 , wherein said peptide in the fruit of said plant is effective to decrease plasma levels of lysophosphatidic acid (LPA) in a mammal when at least a portion of the fruit of said plant is fed to said mammal.

7. The transgenic plant of claim 1 , wherein said peptide in the fruit of said plant is effective to significantly decrease serum amyloid A (SAM levels in a mouse model of atherosclerosis when at least a portion of the fruit of said plant is fed to said mouse.

8. The transgenic plant of claim 1 , wherein said peptide in the fruit of said plant is effective to increase plasma paraoxonase activity in a mammal, when at least a portion of the fruit of said plant is fed to the mammal.

9. The transgenic plant of claim 1 , wherein said peptide is expressed by a nucleic acid construct stably integrated into the plant genome.

10. The transgenic plant of claim 1 , wherein said peptide is expressed under the control of a CaMV promoter.

11. The transgenic plant of claim 1 , wherein said peptide is expressed under the control of an E8 promoter.

12. The transgenic plant of claim 1 , wherein said peptide is expressed under the control of an E4/E8 hybrid promoter.

13. A transgenic seed of a transgenic plant according to claim 1 .

14. A transgenic fruit of a transgenic plant according to claim 1 .

15. A transgenic leaf of a transgenic plant according to claim 1 .

16. A transgenic root or tuber of a transgenic plant according to claim 1 .

17. A cutting of a transgenic plant according to claim 1 .

18. A clone of a transgenic plant according to claim 1 .

19. A food comprising at least a portion of a transgenic plant capable of being ingested for its nutritional value, said plant expressing a peptide comprising an amino acid sequence that is an apolipoprotein or apolipoprotein mimetic, wherein said food comprises a fruit of a transgenic plant according to claim 1 .

20. A protein powder, wherein at least a portion of said protein powder comprises a powdered fruit of a plant according to claim 1 .

21. A nutritional supplement comprising:

a fruit of a transgenic plant according to claim 1 .

22. A powdered fruit of a plant comprising a powdered freeze dried transgenic fruit of a plant according to claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2013
From: FOGELMAN, ALAN M.; REDDY, SRINIVASA T.; NAVAB, MOHAMAD
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 030722/0169 →
CONFIRMATORY LICENSE Recorded Mar 28, 2013
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030106/0315 →
Continuity (3)
Provisional Application 61618753 · Mar 31, 2012
Provisional Application 61716322 · Oct 19, 2012
Related Publication 20130344173A1 · Dec 26, 2013